Sign in

NCT05716906Active, not recruiting

Melatonin and Sleep Spindles in Autism

The Effects of Melatonin on Sleep Spindles in Children With Autism

Source: ClinicalTrials.gov · Last updated 20 Apr 2026

Brief summary (registry, in English)

Sleep disturbances and sensory sensitivities are common disabling features of autism, but their underlying causes are not clear. We hypothesize that both of these difficulties reflect disrupted communication between a deep brain structure, the thalamus, and the brain's outer layer, the cortex. This communication is mediated by the thalamic reticular nucleus (TRN). Due to its small size and location deep in the brain, we cannot assess TRN function without invasive techniques. Fortunately, sleep spindles, a specific brain rhythm provide a noninvasive read-out of TRN function. In Aim 1 we will examine whether reduced sleep spindles are related to worse sleep quality, impaired selective attention during wake, and sensory sensitivities in children with autism. In Aim 2, we will determine whether melatonin, which is commonly used to improve sleep, also increases sleep spindles in autism. If successful, this study will introduce TRN as a target for treatment of sleep disruption and guide larger home-based sleep studies.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
30 (estimated)
First submitted
30 Jan 2023
Start date
11 Jan 2023
Primary completion date
5 Jun 2024
Lead sponsor
Massachusetts General Hospital
Diseases
Autism
NCT number
NCT05716906

What you commit to

  • Study type: Interventional
  • Planned participants: 30
  • From 11 Jan 2023 to the primary completion date, 5 Jun 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study design.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Currently taking melatonin or those who have had an adverse reaction to melatonin in the past

Other illness

  • Chronic medical conditions that affect sleep
  • Any unstable chronic medical condition such as asthma, diabetes, cystic fibrosis, or cardiac disease
  • History of head injury resulting in prolonged loss of consciousness or other neurological sequelae
  • Other neurological disorder, including seizure disorder
  • Diagnosed sleep disorder

Other

  • Pregnant or breastfeeding
  • Substance abuse or dependence within the past six months (nicotine abuse or dependence is not exclusionary)
  • IQ \<70
  • Known genetic causes of ASD

Who the study is looking for

  • Male and female subjects with ASD
  • 12-18 years of age
  • English speaking
  • Able to understand and respond to questionnaires in English

Age in the registry: 12 years to 18 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Massachusetts General Hospital
Coordinator of this site? Confirm its status
BostonUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.